Sept. 4 (Bloomberg) -- Amgen Inc.'s Enbrel, Johnson & Johnson’s Remicade and similar drugs for arthritis and autoimmune disorders must carry stronger warnings about fungal infections tied to more than 45 deaths, U.S. regulators said.
Sept. 4 (Bloomberg) -- Amgen Inc.'s Enbrel, Johnson & Johnson’s Remicade and similar drugs for arthritis and autoimmune disorders must carry stronger warnings about fungal infections tied to more than 45 deaths, U.S. regulators said.
